$117.17
-1.91 (-1.60%)
At Close: Jul 31, 2026
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised
01:10pm, Monday, 04'th May 2026
iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
01:11am, Friday, 01'st May 2026
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
07:26pm, Thursday, 30'th Apr 2026
iRhythm Holdings, Inc. (IRTC) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.95 per share a year ago.
iRhythm Holdings Announces First Quarter 2026 Financial Results
04:05pm, Thursday, 30'th Apr 2026
SAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent d
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference
04:05pm, Tuesday, 28'th Apr 2026
SAN FRANCISCO, April 28, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict di
Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 days of continuous, uninterrupted monitoring with Zio ®
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
04:05pm, Thursday, 16'th Apr 2026
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict di
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
06:44pm, Thursday, 09'th Apr 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
09:49am, Thursday, 09'th Apr 2026
NEW YORK, April 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breache
Head-To-Head Survey: MSP Recovery (NASDAQ:MSPR) & iRhythm Technologies (NASDAQ:IRTC)
01:09am, Monday, 06'th Apr 2026
MSP Recovery (NASDAQ: MSPR - Get Free Report) and iRhythm Technologies (NASDAQ: IRTC - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies bas
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
12:41pm, Wednesday, 01'st Apr 2026
iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the outlook.
Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using the Zio ® ambulatory ECG portfolio. 1,2 Chief Medical Officer Mintu Tu
Assenagon Asset Management S.A. Grows Stock Position in iRhythm Technologies $IRTC
03:07am, Thursday, 26'th Mar 2026
Assenagon Asset Management S.A. grew its stake in iRhythm Technologies (NASDAQ: IRTC) by 189.2% in the undefined quarter, according to the company in its most recent filing with the Securities and Exc
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund
03:27pm, Friday, 20'th Mar 2026
RTW Investments acquired 1,181,990 IRTC shares during Q4 2025, with an estimated position value of $210 million based on the 13F reported at quarter-end. The position represents 2.1% of RTW's 13F repo
Cinctive Capital Management LP Takes $4.82 Million Position in iRhythm Technologies $IRTC
04:30am, Monday, 16'th Mar 2026
Cinctive Capital Management LP acquired a new stake in shares of iRhythm Technologies (NASDAQ: IRTC) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
Sign In
Buy IRTC